@article{ref1,
title="A clinical framework for assessing cannabis-related impairment risk",
journal="Frontiers in psychiatry",
year="2022",
author="MacCallum, Caroline A. and Lo, Lindsay A. and Pistawka, Carly A. and Christiansen, April and Boivin, Michael and Snider-Adler, Melissa",
volume="13",
number="",
pages="e883517-e883517",
abstract="Clinicians play an important role in promoting safe and responsible medical cannabis use. One essential component to safe use is considering a patient's risk of neurocognitive impairment. However, there remains a lack of practical guidance on how clinicians can evaluate this risk for medical cannabis patients. Here, a practical framework is presented for clinicians to assess and stratify cannabis-associated impairment risk. The proposed framework is intended to practically guide healthcare providers in gaining a more comprehensive review of a patient's impairment-related factors. This framework can be used to assess impairment risk for patients currently using or considering medical cannabis and is recommended for all patients who perform safety-sensitive duties. Healthcare providers (HCP) managing patient's medical cannabis or those conducting assessments to determine risk of impairment for safety-sensitive workplaces can utilize this framework to stratify patients' risk of impairment. Such assessments can inform patient-specific needs for support, education, and guidance, to ensure cannabis is used safely and responsibly.<p /> <p>Language: en</p>",
language="en",
issn="1664-0640",
doi="10.3389/fpsyt.2022.883517",
url="http://dx.doi.org/10.3389/fpsyt.2022.883517"
}